Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)
Status:
Completed
Trial end date:
2008-08-21
Target enrollment:
Participant gender:
Summary
This is a comparative study to investigate the safety and efficacy of fidaxomicin versus
vancomycin in subjects with Clostridium difficile-Associated Diarrhea (CDAD).